{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:47:34Z","timestamp":1793400454514,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to examine hTERC gene in different grades of cervical intraepithelial neoplasia (CIN) and cervical cancer, and the association between hTERC and high risk-human papillomavirus (HR-HPV) infection. Patients who underwent cervical cancer screening at the Second Affiliated Hospital of Kunming Medical University between October 2010 and December 2011 were enrolled. All patients underwent liquid-based cytology test and hybrid capture 2 (HC2) for HPV detection. hTERC was examined using fluorescence <jats:italic>in situ<\/jats:italic> hybridization (FISH). Cervical colposcopy biopsy was performed if any of the three results was positive. HC2, FISH, and pathology were compared. A total of 1200 women underwent screening, 150 patients underwent cervical biopsy: 32 in the normal group, 38 in the CIN1 group, 66 in the CIN2\/3 group, and 14 in the invasive cervical cancer group. More patients had HR-HPV infection in the CIN2\/3 group and ICC group compared with the CIN1 group. hTERC increased with increasing histological dysplasia. There was significant difference in hTERC positive rate between each of the three groups. More patients with hTERC gene amplification were observed in the positive HR-HPV group than in the HR-HPV negative group. In conclusion, hTERC is a potential marker for precancerous cervical cancer lesions. hTERC might be correlated with HR-HPV infection in cervical diseases.<\/jats:p>","DOI":"10.1038\/s41598-019-52195-5","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T11:03:13Z","timestamp":1572865393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Human papillomavirus and human telomerase RNA component gene in cervical cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pianping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daizhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"52195_CR1","unstructured":"International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2008 Available from, http:\/\/globocan.iarc.fr\/."},{"key":"52195_CR2","unstructured":"WHO\/ICO Information Centre on Human Papilloma Vrus (HPV) and Cervical Cancer Available from, http:\/\/www.who.int\/hpvcentre."},{"key":"52195_CR3","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"M Arbyn","year":"2011","unstructured":"Arbyn, M. et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 22, 2675\u20132686 (2011).","journal-title":"Ann Oncol."},{"key":"52195_CR4","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.7314\/APJCP.2015.16.17.7401","volume":"16","author":"J Di","year":"2015","unstructured":"Di, J., Rutherford, S. & Chu, C. Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China. Asian Pac J Cancer Prev. 16, 7401\u20137407 (2015).","journal-title":"Asian Pac J Cancer Prev."},{"key":"52195_CR5","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/bjc.2016.290","volume":"115","author":"R Landy","year":"2016","unstructured":"Landy, R., Pesola, F., Castanon, A. & Sasieni, P. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 115, 1140\u20131146 (2016).","journal-title":"Br J Cancer."},{"issue":"Suppl 3","key":"52195_CR6","first-page":"S3\/42","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki, A. B., Schiffman, M., Kjaer, S. & Villa, L. L. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 24(Suppl 3), S3\/42\u201351 (2006).","journal-title":"Vaccine."},{"key":"52195_CR7","first-page":"2218","volume":"14","author":"AH Russell","year":"2004","unstructured":"Russell, A. H., Seiden, M. V. & Duska, L. R. Cancers of the cervix, vagina and vulva. Clinical Oncology. 14, 2218\u20132241 (2004).","journal-title":"Clinical Oncology."},{"key":"52195_CR8","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/cncr.30588","volume":"123","author":"TA Berman","year":"2017","unstructured":"Berman, T. A. & Schiller, J. T. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 123, 2219\u20132229 (2017).","journal-title":"Cancer."},{"key":"52195_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/CS20050369","volume":"110","author":"J Doorbar","year":"2006","unstructured":"Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 110, 525\u2013541 (2006).","journal-title":"Clin Sci (Lond)."},{"key":"52195_CR10","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham, S. V. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 131, 2201\u20132221 (2017).","journal-title":"Clin Sci (Lond)."},{"key":"52195_CR11","first-page":"6027","volume":"60","author":"N Ylitalo","year":"2000","unstructured":"Ylitalo, N. et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res. 60, 6027\u20136032 (2000).","journal-title":"Cancer Res."},{"key":"52195_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","volume":"166","author":"K Heselmeyer-Haddad","year":"2005","unstructured":"Heselmeyer-Haddad, K. et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol. 166, 1229\u20131238 (2005).","journal-title":"Am J Pathol."},{"key":"52195_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/15476286.2016.1205768","volume":"13","author":"JD Podlevsky","year":"2016","unstructured":"Podlevsky, J. D. & Chen, J. J. Evolutionary perspectives of telomerase RNA structure and function. RNA Biol. 13, 720\u2013732 (2016).","journal-title":"RNA Biol."},{"key":"52195_CR14","first-page":"301","volume":"16","author":"T Nowak","year":"2006","unstructured":"Nowak, T. et al. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. Oncol Rep. 16, 301\u2013305 (2006).","journal-title":"Oncol Rep."},{"issue":"3","key":"52195_CR15","doi-asserted-by":"publisher","first-page":"160338","DOI":"10.1098\/rsob.160338","volume":"7","author":"Christine A. Armstrong","year":"2017","unstructured":"Armstrong, C. A., Tomita, K. Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells. Open Biol. 7 (2017).","journal-title":"Open Biology"},{"key":"52195_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/IGC.0b013e31828f39a0","volume":"23","author":"X Zheng","year":"2013","unstructured":"Zheng, X. et al. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions. Int J Gynecol Cancer. 23, 785\u2013790 (2013).","journal-title":"Int J Gynecol Cancer."},{"key":"52195_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ygyno.2008.01.040","volume":"110","author":"NP Caraway","year":"2008","unstructured":"Caraway, N. P. et al. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol. 110, 37\u201342 (2008).","journal-title":"Gynecol Oncol."},{"key":"52195_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0649-0","volume":"32","author":"F Li","year":"2015","unstructured":"Li, F. & Cui, J. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells. Med Oncol. 32, 199 (2015).","journal-title":"Med Oncol."},{"key":"52195_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bjc.6603253","volume":"95","author":"S Andersson","year":"2006","unstructured":"Andersson, S. et al. Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer. 95, 331\u2013338 (2006).","journal-title":"Br J Cancer."},{"key":"52195_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1128\/MCB.21.4.990-1000.2001","volume":"21","author":"CK Lai","year":"2001","unstructured":"Lai, C. K., Mitchell, J. R. & Collins, K. RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol. 21, 990\u20131000 (2001).","journal-title":"Mol Cell Biol."},{"key":"52195_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1746-1596-7-147","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu, H. et al. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol. 7, 147 (2012).","journal-title":"Diagn Pathol."},{"key":"52195_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000438719","volume":"59","author":"R Zappacosta","year":"2015","unstructured":"Zappacosta, R. et al. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology. Acta Cytol. 59, 345\u2013354 (2015).","journal-title":"Acta Cytol."},{"key":"52195_CR23","first-page":"797","volume":"16","author":"H Bin","year":"2013","unstructured":"Bin, H. et al. Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer. Iran J Basic Med Sci. 16, 797\u2013802 (2013).","journal-title":"Iran J Basic Med Sci."},{"key":"52195_CR24","first-page":"168","volume":"21","author":"A Torrisi","year":"2000","unstructured":"Torrisi, A. et al. Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV-negative women. Eur J Gynaecol Oncol. 21, 168\u2013172 (2000).","journal-title":"Eur J Gynaecol Oncol."},{"key":"52195_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers, J. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189, 12\u201319 (1999).","journal-title":"J Pathol."},{"key":"52195_CR26","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","volume":"94","author":"PE Castle","year":"2002","unstructured":"Castle, P. E. et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 94, 1406\u20131414 (2002).","journal-title":"J Natl Cancer Inst."},{"key":"52195_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz, N. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348, 518\u2013527 (2003).","journal-title":"N Engl J Med."},{"key":"52195_CR28","first-page":"2365","volume":"62","author":"K Heselmeyer-Haddad","year":"2002","unstructured":"Heselmeyer-Haddad, K. et al. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer. Cancer Res. 62, 2365\u20132369 (2002).","journal-title":"Cancer Res."},{"key":"52195_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0165-4608(01)00510-6","volume":"131","author":"YC Yang","year":"2001","unstructured":"Yang, Y. C. et al. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet. 131, 48\u201353 (2001).","journal-title":"Cancer Genet Cytogenet."},{"key":"52195_CR30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)63498-0","volume":"163","author":"K Heselmeyer-Haddad","year":"2003","unstructured":"Heselmeyer-Haddad, K. et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol. 163, 1405\u20131416 (2003).","journal-title":"Am J Pathol."},{"key":"52195_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cancergencyto.2009.01.004","volume":"191","author":"Z Tu","year":"2009","unstructured":"Tu, Z. et al. Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders. Cancer Genet Cytogenet. 191, 10\u201316 (2009).","journal-title":"Cancer Genet Cytogenet."},{"key":"52195_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1349-7006.1997.tb00432.x","volume":"88","author":"Y Ohta","year":"1997","unstructured":"Ohta, Y., Tsutsumi, K., Kikuchi, K. & Yasumoto, S. Two distinct human uterine cervical epithelial cell lines established after transfection with human papillomavirus 16 DNA. Jpn J Cancer Res. 88, 644\u2013651 (1997).","journal-title":"Jpn J Cancer Res."},{"key":"52195_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4149\/neo_2015_017","volume":"62","author":"P Kuglik","year":"2015","unstructured":"Kuglik, P. et al. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas. Neoplasma. 62, 130\u2013139 (2015).","journal-title":"Neoplasma."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52195-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:18:07Z","timestamp":1671290287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52195-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52195"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52195-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15926"}}